Seeking Alpha

Shockwave Medical: Timing The Waves Of Opportunity

As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...
TCTMD

TCT 133: Shockwave Balloon or Atherectomy with Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Seeking Alpha

ShockWave Medical: A Hidden Gem In The Medical Device Sector

ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
MD&M East

Boston Sci Rumored to Be Interested in Acquiring Shockwave

Boston Scientific drove the cardiovascular space into a frenzy on Friday when it was announced it was rumored to acquire Shockwave Medical, according to a report from Bloomberg citing people with ...
Healio

DISRUPT PAD: Lithoplasty system successfully treats calcified lesions in patients with PAD

LAS VEGAS — A lithoplasty device was associated with positive 6-month outcomes in patients with symptomatic calcified femoropopliteal lesions, according to the results of the DISRUPT PAD study. The ...
TCTMD

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial

Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry Receive the the latest news, research, and ...